Principal Investigator
Estelamari Rodriguez
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240314
Clinical Trial Summary
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating The Efficacy And Safety Of Divarasib Versus Sotorasib Or Adagrasib In Patients With Previously Treated KRAS G12C-Positive Advanced Or Metastatic Non-Small Cell Lung Cancer
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647